When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARQL - Guardant Health: Bright Future For Liquid Biopsy Leader But Valuation Is Rich
ArQule Inc.
Shares of Guardant Health (GH) have been on quite a run since its IPO priced at $19 in October of last year. In fact, in just a few short months, the stock was a five bagger at one point in March.
The leader in liquid biopsy testing was identified by multiple ROTY members as an intriguing story worth paying attention to and potentially purchasing a stake in. However, when I looked a couple of months ago, I wasn't willing to consider Guardant for ROTY due to an exorbitant valuation (no matter how much